Pharmacokinetics and safety of dexlansoprazole MR in pediatric patients with symptomatic gastroesophageal reflux disease

por Kukulka, Michael, Nudurupati, Sai, Perez, Maria Claudia
Publicado 2014

Bioavailability, safety, and pharmacodynamics of delayed-release dexlansoprazole administered as two 30 mg orally disintegrating tablets or one 60 mg capsule

por Kukulka, Michael, Nudurupati, Sai, Perez, Maria Claudia
Publicado 2016

Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole

por Kukulka, Michael, Nudurupati, Sai, Perez, Maria Claudia
Publicado 2016

Bioavailability of a dexlansoprazole delayed-release orally disintegrating tablet: effects of food and mode of administration

por Kukulka, Michael, Nudurupati, Sai, Perez, Maria Claudia
Publicado 2017

Unmet Needs in Pediatric Functional Constipation

por Sood, Manu, Lichtlen, Peter, Perez, Maria Claudia
Publicado 2018

Bioavailability of dexlansoprazole delayed-release capsule granules when administered via nasogastric tube or orally via syringe

por Kukulka, Michael, Nudurupati, Sai, Perez, Maria Claudia
Publicado 2018

Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease

por Gold, Benjamin D., Pilmer, Betsy, Kierkuś, Jaroslaw, Hunt, Barbara, Perez, Maria Claudia, Gremse, David
Publicado 2017

Dual Delayed-Release Dexlansoprazole for Healing and Maintenance of Healed Erosive Esophagitis: A Safety Study in Adolescents

por Gremse, David, Gold, Benjamin D., Pilmer, Betsy, Hunt, Barbara, Korczowski, Bartosz, Perez, Maria Claudia
Publicado 2018